Adjuvant endocrine therapy for premenopausal women with early breast cancer

被引:52
作者
Dellapasqua, S
Colleoni, M
Gelber, RD
Goldhirsch, A
机构
[1] European Inst Oncol, Div Med Oncol, Dept Med, I-20141 Milan, Italy
[2] Int Breast Canc Study Grp Coordinating Ctr, Bern, Switzerland
[3] Oncol Inst So Switzerland, Bellinzona, Switzerland
[4] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Int Breast Canc Study Grp Stat Ctr, Boston, MA 02115 USA
[5] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA
关键词
D O I
10.1200/JCO.2005.11.050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1736 / 1750
页数:15
相关论文
共 100 条
[91]   Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years [J].
Stewart, HJ ;
Prescott, RJ ;
Forrest, APM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (06) :456-462
[92]   Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer [J].
Stewart, HJ ;
Forrest, AP ;
Everington, D ;
McDonald, CC ;
Dewar, JA ;
Hawkins, RA ;
Prescott, RJ ;
George, WD .
BRITISH JOURNAL OF CANCER, 1996, 74 (02) :297-299
[93]  
Stone E. R., 2000, Breast Cancer Research and Treatment, V64, P61
[94]   A multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: An intergroup study [J].
Taylor, CW ;
Green, S ;
Dalton, WS ;
Martino, S ;
Rector, D ;
Ingle, JN ;
Robert, NJ ;
Budd, GT ;
Paradelo, JC ;
Natale, RB ;
Bearden, JD ;
Mailliard, JA ;
Osborne, CK .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :994-999
[95]   Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status [J].
Thomson, CS ;
Twelves, CJ ;
Mallon, EA ;
Leake, RE .
BREAST, 2002, 11 (05) :419-429
[96]   Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy:: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer?: First results of International Breast Cancer Study Group Trial 11-93 [J].
Thürlimann, B ;
Price, KN ;
Castiglione, M ;
Coates, AS ;
Goldhirsch, A ;
Gelber, RD ;
Forbes, J ;
Holmberg, S ;
Veronesi, A ;
Bernhard, J ;
Zahrieh, D .
BREAST, 2001, 10 :130-138
[97]  
TORMEY DC, 1990, CANCER, V65, P2000
[98]   TAMOXIFEN RESISTANCE IN BREAST-CANCER [J].
WIEBE, VJ ;
OSBORNE, CK ;
FUQUA, SAW ;
DEGREGORIO, MW .
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1993, 14 (03) :173-188
[99]  
WITTLIFF JL, 1991, BREAST COMPREHENSIVE, P900
[100]   High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma:: comparison with biochemical determination in a prospective study of 793 cases [J].
Zafrani, B ;
Aubriot, MH ;
Mouret, E ;
de Crémoux, P ;
de Rycke, Y ;
Nicolas, A ;
Boudou, E ;
Vincent-Salomon, A ;
Magdelénat, H ;
Sastre-Garau, X .
HISTOPATHOLOGY, 2000, 37 (06) :536-545